Financial reports
10-Q
2016 Q3
Quarterly report
10 Nov 16
10-Q
2016 Q2
Quarterly report
11 Aug 16
10-Q
2016 Q1
Quarterly report
12 May 16
10-K
2015 FY
Annual report
25 Mar 16
10-Q
2015 Q3
Quarterly report
12 Nov 15
10-Q
2015 Q2
Quarterly report
7 Aug 15
10-Q
2015 Q1
Quarterly report
14 May 15
ARS
2014 FY
Annual report to shareholders
11 May 15
10-K
2014 FY
Annual report
17 Mar 15
10-Q
2014 Q3
Quarterly report
12 Nov 14
Current reports
8-K
Termination of a Material Definitive Agreement
1 Mar 17
8-K
WaferGen Bio-systems Reports Revenue Growth in Fourth Quarter of 2016
15 Feb 17
8-K
WaferGen Bio-systems Announces 1-for-5 Reverse Stock Split
28 Nov 16
8-K
WaferGen Bio-systems Announces Stockholder Approval of Merger with Takara Bio
15 Nov 16
8-K
WaferGen Bio-systems Reports Results for Third Quarter 2016
8 Nov 16
8-K
WaferGen Bio-systems Reports Strong Revenue Growth in Third Quarter of 2016
31 Oct 16
8-K
Results of Operations and Financial Condition
28 Oct 16
8-K
WaferGen Bio-systems Announces Adjournment of Special Meeting of Stockholders
27 Oct 16
8-K
WaferGen Bio-systems Reports Results for Second Quarter 2016
9 Aug 16
8-K
Departure of Directors or Certain Officers
26 May 16
Registration and prospectus
POS AM
Prospectus update (post-effective amendment)
13 Mar 17
15-12G
Securities registration termination
13 Mar 17
POSASR
Automatic shelf registration (post-effective amendment)
13 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Mar 17
POS AM
Prospectus update (post-effective amendment)
13 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Mar 17
POS AM
Prospectus update (post-effective amendment)
13 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Mar 17
Proxies
DEFA14A
Additional proxy soliciting materials
8 Nov 16
DEFA14A
Additional proxy soliciting materials
31 Oct 16
DEFA14A
Additional proxy soliciting materials
28 Oct 16
DEFA14A
Additional proxy soliciting materials
27 Oct 16
DEFA14A
Additional proxy soliciting materials
18 Oct 16
DEFM14A
Proxy related to merger
15 Sep 16
PRER14A
Preliminary revised proxy
30 Aug 16
DEFA14A
Additional proxy soliciting materials
9 Aug 16
PREM14A
Preliminary proxy related to merger
10 Jun 16
DEFA14A
Additional proxy soliciting materials
18 May 16
Other
EFFECT
Notice of effectiveness
13 Mar 17
EFFECT
Notice of effectiveness
13 Mar 17
EFFECT
Notice of effectiveness
13 Mar 17
UPLOAD
Letter from SEC
20 Sep 16
UPLOAD
Letter from SEC
13 Sep 16
CORRESP
Correspondence with SEC
13 Sep 16
CORRESP
Correspondence with SEC
29 Aug 16
UPLOAD
Letter from SEC
17 Aug 16
CORRESP
Correspondence with SEC
4 Aug 16
UPLOAD
Letter from SEC
21 Jul 16
Ownership
4
IVAN TRIFUNOVICH
1 Mar 17
4
William Douglas McKenzie
1 Mar 17
4
JOEL S KANTER
1 Mar 17
4
R Dean Hautamaki
1 Mar 17
4
Makoto Kaneshiro
1 Mar 17
4
Michael P Henighan
1 Mar 17
4
Rolland Carlson
1 Mar 17
4
Robert Alan Schueren
1 Mar 17
SC 13G/A
WaferGen Bio-systems, Inc.
23 Feb 17
SC 13G/A
WaferGen Bio-systems, Inc.
6 Jan 17